Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Chung HK, Liu C, Battu A, Jambor AN, Pratt BM, Xie F, Riesenberg BP, Casillas E, Sun M, Landoni E, Li Y, Ye Q, Joo D, Green J, Syed Z, Brown NJ, Smith M, Ma S, Tan S, Chick B, Tripple V, Wang ZA, Wang J, Mcdonald B, He P, Yang Q, Chen T, Varanasi SK, LaPorta MA, Mann TH, Chen D, Hoffmann F, Ho J, Modliszewski J, Williams A, Liu Y, Wang Z, Liu J, Gao Y, Hu Z, Cho UH, Liu L, Wang Y, Hargreaves DC, Dotti G, Savoldo B, Thaxton JE, Milner JJ, Kaech SM, Wang W. Atlas-guided discovery of transcription factors for T cell programming. Nature. 2026 03; 651(8107):1077-1087.
-
Daee D, Behm M, Marcus PM, Rosenfield SM, Rotunno M, Cronin KA, Kobrin SC, Gillanders EM. The Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2026 Feb 03; 35(2):193-197.
-
Zhan X, Xiao H, Wang Q, Luo J, Ma L, Zhang X, Tang J, Meng X. Natural killer cell nano-engagers drive ferroptosis-immunomodulation synergy via inhibition of the Interleukin-6-JAK2-STAT3 Axis. J Control Release. 2026 Feb 10; 390:114581.
-
Nayak MM, Chai PR, Tung S, Revette A, Braun IM. Medical Cannabis Formulations, Administration Routes, and Dosing: Perspectives of Patients With Cancer Who Consume. Clin Ther. 2026 Jan; 48(1):51-56.
-
Webster MA, Burris JL, Cipri C, Bird J, Hayes RB, Sheffer CE, Khanna N, Lenhoff K, Minion M, Tong EK. A mixed-methods study exploring free nicotine replacement therapy as a strategy to promote tobacco treatment equity at Cancer Center Cessation Initiative sites. Support Care Cancer. 2025 Dec 09; 34(1):17.
-
Pearson LK, Zheng Y, Nikita N, Lu-Yao G, Presley CJ, Wagner LI, Simon MA, Dotan E. Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience. J Natl Compr Canc Netw. 2025 Dec; 23(12).
-
Gao Y, Du C, Xu Y, Cheng X, Zhao H, Jiang F, Cheng N, Xiang Y, Zhang Y, Li Y, Liu H, Chai X, Lian X, Zhao W, Li N. Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):3342-3353.
-
Lee JA, Pakpahan R, Amante DJ, Gerber BS, Yang L. Comorbidity prevalence and incidence in cancer survivors: a longitudinal All of Us study. JNCI Cancer Spectr. 2025 Nov 03; 9(6).
-
Lines LM, Fujita M, Danforth KN, Barch DH, Halpern MT, Mollica MA, Eton DT, Smith AW. Hospice, palliative care, and care experiences among Medicare beneficiaries with cancer. J Geriatr Oncol. 2026 01; 17(1):102795.
-
Savas S, Crichton K, Wiseman J, Taylor-Cutting J, Slaney T. Podcasting and Blogging as Tools to Engage with the Public on the Topic of Cancer: Experience and Perspectives of the Public Interest Group on Cancer Research. Curr Oncol. 2025 Oct 18; 32(10).